Episode: 77 - Derek Lowe on AI and the US Biotech Ecosystem
- Author
- Cambridge Healthtech Institute
- Published
- Tue 16 Sep 2025
- Episode Link
- None
September 16, 2025 | With the rise of AI and automation, what is the core human skill in drug discovery that is and will be valuable in the future? Derek Lowe, director of Chemical Biology Therapeutics at Novartis and author of the In the Pipeline blog, discusses the impact of AI—and non-AI technologies—on the business of drug making. With host Christopher Bahl, cofounder and CEO of AI Proteins, their conversation covers the value of a PhD in the tech world today, the long-term impacts of knowledge creation in US leadership positions, how the industry can navigate a biotech winter, and more.
Links from this episode:
AI Proteins
Novartis
In the Pipeline
